DOI . ORG {}

Matching Content Categories {📚}

• Health & Fitness
• Education
• Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't figure out the monetization strategy.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Doi.org could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cancer, prostate, google, scholar, article, pubmed, docetaxel, cas, chemotherapy, patients, oncol, phase, castrationresistant, metastatic, study, clin, secondline, hormonerefractory, therapy, mitoxantrone, prednisone, trial, refractory, abstract, combination, proc, genitourinary, cancers, symposium, poster, session, treatment, survival, crpc, androgenindependent, androgen, randomized, hormone, oncology, docetaxelresistant, results, resistance, advanced, urol, res, ryan, colloca, progression, docetaxelpretreated, receptor,

Topics {✒️}

month download article/chapter castration-resistant prostate cancer hormone-resistant prostate cancer hormone-refractory prostate cancer castrate-resistant prostate cancer androgen-independent prostate cancer absolute prostate-specific antigen docetaxel-refractory prostate cancer docetaxel-resistant breast cancer anti-il-6 monoclonal antibody metastatic castration-resistant continued androgen-deprivation therapy double-blinded randomized comparison metastatic prostate cancer 2nd/3rd line therapy drug-free interval randomised open-label trial initial docetaxel-based chemotherapy 1st-line docetaxel therapy giuseppe colloca metastatic tumor growth de bono js primary prostate cancer weekly high-dose calcitriol advanced prostate cancer docetaxel/carboplatin-based chemotherapy full article pdf line taxane-based chemotherapy related subjects article colloca clin prostate cancer castration-resistance crpc privacy choices/manage cookies androgen ablation therapy secondary hormonal therapy androgen receptor mutations androgen receptor antagonists human prostate carcinoma docetaxel-based therapy author information authors cancer chemother pharmacol genes potentially involved castration resistance strong independent predictor high-dose calcitriol canadian randomized trial docetaxel-based chemotherapy taxane-based chemotherapy clin cancer res prior taxane therapy

Questions {❓}

• Chemotherapy in androgen-independent prostate cancer (AIPC): what’s next after taxane progression?
• First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer: does sequence matter?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Second-line chemotherapy in metastatic docetaxel-resistant prostate cancer: a review
         description:The results of cytotoxic therapy in the second-line setting of metastatic castration-resistant prostate cancer have demonstrated that disease is poorly controlled after taxane resistance with a time to progression of 3 months or less. Many trials of second-line chemotherapy have been disappointing. However, most of patients with docetaxel-pretreated castration-resistant disease receive a second-line chemotherapy. Molecular mechanism of castration resistance and docetaxel resistance is resumed, and clinical trials of second-line chemotherapy after docetaxel progression are reviewed. Reintroduction of docetaxel after a drug-free interval is an active treatment in docetaxel-pretreated patients, and only recently a prospective study documented a survival benefit of 2.4 months after second-line taxane-based chemotherapy of metastatic docetaxel-resistant prostate cancer. Although a second-line chemotherapy with a taxane could improve overall survival, a change of biology of castration-resistant prostate cancer after docetaxel is suggested, as inferred by the renewed hormonal sensitivity, whose role on survival remains unknown, and from the activity of antiangiogenic drugs.
         datePublished:2011-02-20T00:00:00Z
         dateModified:2011-02-20T00:00:00Z
         pageStart:776
         pageEnd:785
         sameAs:https://doi.org/10.1007/s12032-011-9855-6
         keywords:
            Castration-resistance
            Chemotherapy
            Docetaxel
            Prostate cancer
            Oncology
            Hematology
            Pathology
            Internal Medicine
         image:
         isPartOf:
            name:Medical Oncology
            issn:
               1559-131X
               1357-0560
            volumeNumber:29
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Giuseppe Colloca
               affiliation:
                     name:“Giovanni Borea” Hospital
                     address:
                        name:Division of Medical Oncology, “Giovanni Borea” Hospital, Sanremo, Italy
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Antonella Venturino
               affiliation:
                     name:“Giovanni Borea” Hospital
                     address:
                        name:Division of Medical Oncology, “Giovanni Borea” Hospital, Sanremo, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Franco Checcaglini
               affiliation:
                     name:ASL-1 Umbria
                     address:
                        name:Department of Radiotherapy, ASL-1 Umbria, Città di Castello, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Second-line chemotherapy in metastatic docetaxel-resistant prostate cancer: a review
      description:The results of cytotoxic therapy in the second-line setting of metastatic castration-resistant prostate cancer have demonstrated that disease is poorly controlled after taxane resistance with a time to progression of 3 months or less. Many trials of second-line chemotherapy have been disappointing. However, most of patients with docetaxel-pretreated castration-resistant disease receive a second-line chemotherapy. Molecular mechanism of castration resistance and docetaxel resistance is resumed, and clinical trials of second-line chemotherapy after docetaxel progression are reviewed. Reintroduction of docetaxel after a drug-free interval is an active treatment in docetaxel-pretreated patients, and only recently a prospective study documented a survival benefit of 2.4 months after second-line taxane-based chemotherapy of metastatic docetaxel-resistant prostate cancer. Although a second-line chemotherapy with a taxane could improve overall survival, a change of biology of castration-resistant prostate cancer after docetaxel is suggested, as inferred by the renewed hormonal sensitivity, whose role on survival remains unknown, and from the activity of antiangiogenic drugs.
      datePublished:2011-02-20T00:00:00Z
      dateModified:2011-02-20T00:00:00Z
      pageStart:776
      pageEnd:785
      sameAs:https://doi.org/10.1007/s12032-011-9855-6
      keywords:
         Castration-resistance
         Chemotherapy
         Docetaxel
         Prostate cancer
         Oncology
         Hematology
         Pathology
         Internal Medicine
      image:
      isPartOf:
         name:Medical Oncology
         issn:
            1559-131X
            1357-0560
         volumeNumber:29
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Giuseppe Colloca
            affiliation:
                  name:“Giovanni Borea” Hospital
                  address:
                     name:Division of Medical Oncology, “Giovanni Borea” Hospital, Sanremo, Italy
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Antonella Venturino
            affiliation:
                  name:“Giovanni Borea” Hospital
                  address:
                     name:Division of Medical Oncology, “Giovanni Borea” Hospital, Sanremo, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Franco Checcaglini
            affiliation:
                  name:ASL-1 Umbria
                  address:
                     name:Department of Radiotherapy, ASL-1 Umbria, Città di Castello, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Medical Oncology
      issn:
         1559-131X
         1357-0560
      volumeNumber:29
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:“Giovanni Borea” Hospital
      address:
         name:Division of Medical Oncology, “Giovanni Borea” Hospital, Sanremo, Italy
         type:PostalAddress
      name:“Giovanni Borea” Hospital
      address:
         name:Division of Medical Oncology, “Giovanni Borea” Hospital, Sanremo, Italy
         type:PostalAddress
      name:ASL-1 Umbria
      address:
         name:Department of Radiotherapy, ASL-1 Umbria, Città di Castello, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Giuseppe Colloca
      affiliation:
            name:“Giovanni Borea” Hospital
            address:
               name:Division of Medical Oncology, “Giovanni Borea” Hospital, Sanremo, Italy
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Antonella Venturino
      affiliation:
            name:“Giovanni Borea” Hospital
            address:
               name:Division of Medical Oncology, “Giovanni Borea” Hospital, Sanremo, Italy
               type:PostalAddress
            type:Organization
      name:Franco Checcaglini
      affiliation:
            name:ASL-1 Umbria
            address:
               name:Department of Radiotherapy, ASL-1 Umbria, Città di Castello, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Medical Oncology, “Giovanni Borea” Hospital, Sanremo, Italy
      name:Division of Medical Oncology, “Giovanni Borea” Hospital, Sanremo, Italy
      name:Department of Radiotherapy, ASL-1 Umbria, Città di Castello, Italy
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(247)

• Learn about the earnings of https://link.springer.com/privacystatement
• How much revenue does https://link.springer.com/article/10.1007/s12032-011-9855-6/#main bring in?
• Earnings of https://link.springer.com
• How much does https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s12032-011-9855-6 pull in?
• How much cash flow does https://link.springer.com/article/10.1007/s12032-011-9855-6/#eds-c-header-nav have monthly?
• What's the financial gain of https://link.springer.com/journals/?
• Learn about the earnings of https://www.springernature.com/gp/authors
• https://link.springernature.com/home/ income
• What's the income of https://link.springer.com/article/10.1007/s12032-011-9855-6/#eds-c-header-popup-search?
• What's the financial gain of https://order.springer.com/public/cart?
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/ net monthly?
• What's the monthly income of https://link.springer.com/article/10.1007/s12032-011-9855-6/journal/12032?
• Profit of https://link.springer.com/article/10.1007/s12032-011-9855-6/#citeas
• Get to know https://link.springer.com/article/10.1007/s12032-011-9855-6/journal/12032/aims-and-scope's earnings
• Find out how much https://submission.springernature.com/new-submission/12032/3 earns monthly
• Financial intake of https://link.springer.com/article/10.1007/s12032-011-9855-6/#auth-Giuseppe-Colloca-Aff1
• Earnings of https://link.springer.com/article/10.1007/s12032-011-9855-6/#Aff1
• Check the income stats for https://link.springer.com/article/10.1007/s12032-011-9855-6/#auth-Antonella-Venturino-Aff1
• Get to know https://link.springer.com/article/10.1007/s12032-011-9855-6/#auth-Franco-Checcaglini-Aff2's earnings
• What's the financial intake of https://link.springer.com/article/10.1007/s12032-011-9855-6/#Aff2?
• Check the income stats for https://link.springer.com/article/10.1007/s12032-011-9855-6/article/10.1007/s12032-011-9855-6/metrics
• What's the profit of https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs12032-011-9855-6?
• What is the earnings of https://link.springer.com/product/springer-plus?
• How much does https://www.springernature.com/gp/librarians/licensing/agc/journals pull in monthly?
• https://link.springer.com/10.1007/978-3-319-31341-2_6?fromPaywallRec=true income
• Explore the financials of https://link.springer.com/10.1007/978-981-10-7013-6_36?fromPaywallRec=true
• How much income does https://link.springer.com/10.1007/978-981-10-6943-7_21?fromPaywallRec=true have?
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/subjects/cancer-therapy bring in each month?
• What's the monthly income of https://link.springer.com/article/10.1007/s12032-011-9855-6/subjects/cancer-therapeutic-resistance?
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/subjects/chemotherapy bring in each month?
• How much income is https://link.springer.com/article/10.1007/s12032-011-9855-6/subjects/combination-drug-therapy earning monthly?
• Learn about the earnings of https://link.springer.com/article/10.1007/s12032-011-9855-6/subjects/prostate-cancer
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/subjects/urological-cancer pull in monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20116997 pull in?
• How much profit is https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:STN:280:DC%2BC3c7js1CktA%3D%3D making per month?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Estimates%20of%20cancer%20incidence%20and%20mortality%20in%20Europe%20in%202008&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2009.12.014&volume=46&pages=765-781&publication_year=2010&author=Ferlay%2CJ&author=Parkin%2CDM&author=Steliarova-Foucher%2CE
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8656243 pull in monthly?
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DyaK28XjslOrsr8%3D generate monthly?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Chemotherapy%20with%20mitoxantrone%20plus%20prednisone%20or%20prednisone%20alone%20for%20symptomatic%20hormone-resistant%20prostate%20cancer%3A%20a%20Canadian%20randomized%20trial%20with%20palliative%20end%20points&journal=J%20Clin%20Oncol&volume=14&pages=1756-1764&publication_year=1996&author=Tannock%2CIF&author=Osoba%2CD&author=Stockler%2CMR&author=Scott%20Ernst%2CD&author=Neville%2CAJ&author=Moore%2CMJ?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=%2C%20for%20the%20TAX%20327%20Investigators.%20Docetaxel%20plus%20prednisone%20or%20mitoxantrone%20plus%20prednisone%20for%20advanced%20prostate%20cancer&journal=N%20Engl%20J%20Med&volume=351&pages=1502-1512&publication_year=2004&author=Tannock%2CIF&author=Wit%2CR&author=Berry%2CWR&author=Horti%2CJ&author=Pluzanska%2CA&author=Chi%2CKN?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15470214?
• How much money does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2cXot1Kmu7c%3D make?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Docetaxel%20and%20estramustine%20compared%20with%20mitoxantrone%20and%20prednisone%20for%20advanced%20refractory%20prostate%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa041318&volume=351&pages=1513-1520&publication_year=2004&author=Petrylak%2CDP&author=Tangen%2CCM&author=Hussain%2CMH&author=Lara%2CPN&author=Jones%2CJA&author=Taplin%2CME?
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14695335?
• Revenue of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2cXlsVCnsA%3D%3D
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Gene%20expression%20analysis%20of%20human%20prostate%20carcinoma%20during%20hormonal%20therapy%20identifies%20androgen-responsive%20genes%20and%20mechanisms%20of%20therapy%20resistance&journal=Am%20J%20Pathol&doi=10.1016%2FS0002-9440%2810%2963112-4&volume=164&pages=217-227&publication_year=2004&author=Holzbeierlein%2CJ&author=Lal%2CP&author=Tulippe%2CE&author=Smith%2CA&author=Satagopan%2CJ&author=Zhang%2CL?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Localized%20androgen-independent%20prostate%20cancer&journal=Cancer%20Ther&volume=5&pages=485-500&publication_year=2007&author=Colloca%2CG&author=Venturino%2CA&author=Checcaglini%2CF
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12860943
• How much profit does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2cXptlCktLs%3D make?
• Get to know http://scholar.google.com/scholar_lookup?&title=Androgen%20receptor%20mutations%20in%20androgen-independent%20prostate%20cancer%3A%20Cancer%20and%20Leukemia%20Group%20B%20study%209663&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2003.11.102&volume=21&pages=2673-2678&publication_year=2003&author=Taplin%2CME&author=Rajeshkumar%2CB&author=Halabi%2CS&author=Werner%2CCP&author=Woda%2CBA&author=Picus%2CJ's earnings
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7683043's total income per month
• How much cash flow does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:STN:280:DyaK3s3ktVWrsA%3D%3D have monthly?
• http://scholar.google.com/scholar_lookup?&title=Prostate%20specific%20antigen%20decline%20after%20antiandrogen%20withdrawal%3A%20the%20flutamide%20withdrawal%20syndrome&journal=J%20Clin%20Oncol&volume=11&issue=4&pages=607-615&publication_year=1993&author=Kelly%2CWK&author=Scher%2CHI&author=Mazumdar%2CM&author=Vlamis%2CV&author=Schwartz%2CM&author=Fossa%2CSD income
• See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15598662 makes per month
• Check the income stats for https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2MXhsV2qs7c%3D
• What's the income of http://scholar.google.com/scholar_lookup?&title=The%20androgen%20receptor%20recruits%20nuclear%20receptor%20CoRepressor%20%28N-CoR%29%20in%20the%20presence%20of%20mifepristone%20via%20its%20N%20and%20C%20termini%20revealing%20a%20novel%20molecular%20mechanism%20for%20androgen%20receptor%20antagonists&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M408972200&volume=280&pages=6511-6519&publication_year=2005&author=Hodgson%2CMC&author=Astapova%2CI&author=Cheng%2CS&author=Lee%2CLJ&author=Verhoeven%2CMC&author=Choi%2CE?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15020604 make?
• What are the total earnings of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2cXptlCkurc%3D?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Antiandrogen%20withdrawal%20alone%20or%20in%20combination%20with%20ketoconazole%20in%20androgen-independent%20prostate%20cancer%20patients%3A%20a%20phase%20III%20trial%20%28CALGB%209583%29&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2004.06.037&volume=22&pages=1025-1033&publication_year=2004&author=Small%2CEJ&author=Halabi%2CS&author=Dawson%2CNA&author=Stadler%2CWM&author=Rini%2CBI&author=Picus%2CJ
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19414113's total income per month
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD1MXltlegs7c%3D pull in monthly?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Castration-resistant%20prostate%20cancer%3A%20targeting%20androgen%20metabolic%20pathways%20in%20recurrent%20disease&journal=Urol%20Oncol&doi=10.1016%2Fj.urolonc.2009.03.016&volume=27&pages=251-257&publication_year=2009&author=Mostaghel%2CEA&author=Montgomery%2CB&author=Nelson%2CPS?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16203770 income
• How much profit is https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2MXhtVKiur3L making per month?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Molecular%20alterations%20in%20primary%20prostate%20cancer%20after%20androgen%20ablation%20therapy&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-0585&volume=11&pages=6823-6834&publication_year=2005&author=Best%2CCJM&author=Gillespie%2CJW&author=Yi%2CY&author=Chandramouli%2CGVR&author=Perlmutter%2CMA&author=Gathright%2CY?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17013881 earns monthly
• How much revenue does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtVCrsbo%3D produce monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Identification%20of%20genes%20potentially%20involved%20in%20the%20acquisition%20of%20androgen-independent%20and%20metastatic%20tumor%20growth%20in%20an%20autochthonous%20genetically%20engineered%20mouse%20prostate%20cancer%20model&journal=Prostate&doi=10.1002%2Fpros.20505&volume=67&pages=83-106&publication_year=2007&author=Morgenbesser%2CSD&author=McLaren%2CRP&author=Richards%2CB&author=Zhang%2CM&author=Akmaev%2CVR&author=Winter%2CSF pull in?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17913662 pull in monthly?
• Revenue of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtFektbzI
• Get to know http://scholar.google.com/scholar_lookup?&title=Androgen-response%20elements%20in%20hormone-refractory%20prostate%20cancer%3A%20implications%20for%20treatment%20development&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2807%2970316-9&volume=8&pages=933-939&publication_year=2007&author=Hsieh%2CAC&author=Small%2CEJ&author=Ryan%2CCJ's earnings
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17644120's earnings
• Find out how much https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtVWqtLfI earns monthly
• How much money does http://scholar.google.com/scholar_lookup?&title=Taxane%20refractory%20prostate%20cancer&journal=J%20Urol&doi=10.1016%2Fj.juro.2007.04.032&volume=178&pages=S36-S41&publication_year=2007&author=Mathew%2CP&author=DiPaola%2CR generate?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16197608's financial summary
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD28XhslWqsr4%3D make?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Second-line%20chemotherapy%20for%20prostate%20cancer%3A%20patient%20characteristics%20and%20survival&journal=Clin%20Prostate%20Cancer&volume=4&issue=2&pages=86-90&publication_year=2005&author=Beekman%2CKW&author=Fleming%2CMT&author=Scher%2CHI&author=Slovin%2CSF&author=Ishill%2CNM&author=Heller%2CG have monthly?
• How much money does https://link.springer.com/doi/10.1007/s10549-004-2184-0 generate?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15754121?
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2MXitVKlsbo%3D gross monthly?
• http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20weekly%20paclitaxel%20in%20patients%20with%20docetaxel-resistant%20breast%20cancer&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-004-2184-0&volume=89&pages=237-241&publication_year=2005&author=Yonemori%2CK&author=Katsumata%2CN&author=Uno%2CH&author=Matsumoto%2CK&author=Kouno%2CT&author=Tokunaga%2CS's revenue stream
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15780373
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Docetaxel-based%20chemotherapy%20as%20second-line%20treatment%20for%20paclitaxel-based%20chemotherapy-resistant%20hormone-refractory%20prostate%20cancer%3A%20a%20pilot%20study&journal=Urology&doi=10.1016%2Fj.urology.2004.10.033&volume=65&pages=543-548&publication_year=2005&author=Urakami%2CS&author=Yoshino%2CT&author=Kikuno%2CN&author=Imai%2CSH&author=Yoneda%2CT&author=Kishi%2CH?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=for%20the%20TROPIC%20Investigators.%20Prednisone%20plus%20cabazitaxel%20or%20mitoxantrone%20for%20metastatic%20castration-resistant%20prostate%20cancer%20progressing%20after%20docetaxel%20treatment%3A%20a%20randomised%20open-label%20trial&journal=Lancet%20Oncol&volume=376&pages=1147-1154&publication_year=2010&author=Bono%2CJS&author=Oudard%2CS&author=Ozguroglu%2CM&author=Hansen%2CS&author=Machiels%2CJP&author=Kocak%2CI generate?
• Explore the financials of https://link.springer.com/doi/10.1007/s00280-005-0098-0
• What's https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2MXht1Gnu7rK's gross income?
• http://scholar.google.com/scholar_lookup?&title=Beyond%20simple%20castration%3A%20targeting%20the%20molecular%20basis%20of%20treatment%20resistance%20in%20advanced%20prostate%20cancer&journal=Cancer%20Chemother%20Pharmacol&doi=10.1007%2Fs00280-005-0098-0&volume=56&pages=s47-s57&publication_year=2005&author=Gleave%2CM&author=Miyake%2CH&author=Chi%2CK's total income per month
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16921051
• See how much http://scholar.google.com/scholar_lookup?&title=Absolute%20prostate-specific%20antigen%20value%20after%20androgen%20deprivation%20is%20a%20strong%20independent%20predictor%20of%20survival%20in%20new%20metastatic%20prostate%20cancer%3B%20data%20from%20Southwest%20Oncology%20Group%20trial%209346%20%28INT-0162%29&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2006.06.4246&volume=24&pages=3984-3990&publication_year=2006&author=Hussain%2CM&author=Tangen%2CCM&author=Higano%2CC&author=Schelhammer%2CPF&author=Faulkner%2CJ&author=Crawford%2CED makes per month
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8229130?
• What's the profit of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:STN:280:DyaK2c%2FksFyhsw%3D%3D?
• Profit of http://scholar.google.com/scholar_lookup?&title=Importance%20of%20continued%20testicular%20suppression%20in%20hormone-refractory%20prostate%20cancer&journal=J%20Clin%20Oncol&volume=11&pages=2167-2172&publication_year=1993&author=Taylor%2CCD&author=Elson%2CP&author=Trump%2CDL
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8083710
• https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:STN:280:DyaK2czmsFKgsQ%3D%3D's financial summary
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Effects%20of%20continued%20androgen-deprivation%20therapy%20and%20other%20prognostic%20factors%20on%20response%20and%20survival%20in%20phase%20II%20chemotherapy%20trials%20for%20hormone-refractory%20prostate%20cancer%3A%20a%20Southwest%20Oncology%20Group%20report&journal=J%20Clin%20Oncol&volume=12&pages=1868-1875&publication_year=1994&author=Hussain%2CM&author=Wolf%2CM&author=Marshall%2CE&author=Crawford%2CED&author=Eisenberger%2CM?
• How much does http://scholar.google.com/scholar_lookup?&title=Chemotherapy%20in%20androgen-independent%20prostate%20cancer%20%28AIPC%29%3A%20what%E2%80%99s%20next%20after%20taxane%20progression%3F&journal=Cancer%20Ther&volume=5&pages=151-160&publication_year=2007&author=Aragon-Ching%2CJB&author=Dahut%2CWL earn?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19805692 generate?
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD1MXhsFKkt7vJ gross monthly?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Multinational%2C%20double-blind%2C%20phase%20III%20study%20of%20prednisone%20and%20either%20satraplatin%20or%20placebo%20in%20patients%20with%20castrate-refractory%20prostate%20cancer%20progressing%20after%20prior%20chemotherapy%3A%20the%20SPARC%20trial&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.20.1228&volume=27&pages=5431-5438&publication_year=2009&author=Sternberg%2CCN&author=Petrylak%2CDP&author=Sartor%2CO&author=Witjes%2CJA&author=Demkow%2CT&author=Ferrero%2CJM
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17577218?
• How much money does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2sXpt1yqu7o%3D generate?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Activity%20of%20second-line%20chemotherapy%20in%20docetaxel-refractory%20hormone-refractory%20prostate%20cancer%20patients.%20Randomized%20phase%202%20study%20of%20ixabepilone%20or%20mitoxantrone%20and%20prednisone&journal=Cancer&doi=10.1002%2Fcncr.22811&volume=110&pages=556-563&publication_year=2007&author=Rosenberg%2CJE&author=Weinberg%2CVK&author=Kelly%2CWK&author=Michaelson%2CD&author=Hussain%2CMH&author=Wilding%2CG
• How much income does http://scholar.google.com/scholar_lookup?&title=Results%20of%20a%20randomized%20phase%20II%20study%20of%20mitoxantrone%20versus%20mitoxantrone%20with%20cetuximab%20in%20metastatic%20castrate-resistant%20prostate%20cancer%20%28CRPC%29%20previously%20treated%20with%20docetaxel-based%20chemotherapy&journal=J%20Clin%20Oncol&volume=28&issue=15S&publication_year=2010&author=Fleming%2CMT&author=Kolodziej%2CMA&author=Awasthi%2CS&author=Hutson%2CTE&author=Martincic%2CD&author=Sonpavde%2CG have?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Result%20of%20a%20randomized%20phase%20II%20study%20of%20irofulven%20in%20hormone-refractory%20prostate%20cancer%20patients%20that%20have%20failed%20first-line%20docetaxel%20treatment&journal=J%20Clin%20Oncol&volume=25&issue=18S&publication_year=2007&author=Berger%2CER&author=Ciuleanu%2CT&author=Hart%2CL&author=Chi%2CKN&author=Alexandre%2CJ&author=Oudard%2CS?
• Income figures for http://scholar.google.com/scholar_lookup?&title=A%20phase%20II%20randomized%20study%20of%20custirsen%20%28OGX-011%29%20combination%20therapy%20in%20patients%20with%20poor-risk%20hormone%20refractory%20prostate%20cancer%20%28HRPC%29%20who%20relapsed%20on%20or%20within%20six%20months%20of%201st-line%20docetaxel%20therapy&journal=J%20Clin%20Oncol&volume=26&issue=15S&publication_year=2008&author=Saad%2CF&author=Hotte%2CSJ&author=North%2CSA&author=Eigl%2CBJ&author=Chi%2CKN&author=Czaykowski%2CP
• How much does http://scholar.google.com/scholar_lookup?&title=for%20the%20Prostate%20Cancer%20Clinical%20Trials%20Consortium.%20A%20phase%202%20study%20of%20carboplatin%20plus%20docetaxel%20in%20men%20with%20metastatic%20hormone-refractory%20prostate%20cancer%20who%20are%20refractory%20to%20docetaxel&journal=Cancer&volume=112&pages=521-526&publication_year=2008&author=Ross%2CRW&author=Beer%2CTM&author=Jacobus%2CS&author=Bubley%2CGJ&author=Taplin%2CME&author=Ryan%2CCW earn?
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18184327 earning monthly?
• Learn about the earnings of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD1cXis1amt7g%3D
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Response%20to%20docetaxel%2Fcarboplatin-based%20chemotherapy%20as%20first-%20and%20second-line%20therapy%20in%20patients%20with%20metastatic%20hormone-refractory%20prostate%20cancer&journal=BJU%20Int&doi=10.1111%2Fj.1464-410X.2007.07331.x&volume=101&pages=308-312&publication_year=2008&author=Nakabayashi%2CM&author=Sartor%2CO&author=Jacobus%2CS&author=Regan%2CMM&author=McKearn%2CD&author=Ross%2CRW?
• What's the revenue for https://link.springer.com/doi/10.1007/s00345-010-0527-5?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20229232
• How much profit does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BC3cXmtlynsLs%3D generate?
• How much does http://scholar.google.com/scholar_lookup?&title=Carboplatin%20plus%20weekly%20docetaxel%20as%20salvage%20chemotherapy%20in%20docetaxel-resistant%20and%20castration-resistant%20prostate%20cancer&journal=World%20J%20Urol&doi=10.1007%2Fs00345-010-0527-5&volume=28&pages=391-398&publication_year=2010&author=Reuter%2CCW&author=Morgan%2CMA&author=Ivanyi%2CP&author=Fenner%2CM&author=Ganser%2CA&author=Gruenwald%2CV earn?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Oxaliplatin%20and%20docetaxel%20in%20castration-resistant%20prostate%20cancer%20%28CRPC%29%20patients%20treated%20with%20up%20to%20two%20prior%20chemotherapeutic%20regimens%3A%20updated%20results%20of%20a%20phase%20II%20trial&journal=J%20Clin%20Oncol&volume=26&issue=15S&publication_year=2008&author=Chatta%2CGS&author=Feinstein%2CTM&author=Appleman%2CLJ&author=Friedland%2CDM&author=Jacobs%2CSA&author=Evans%2CTL?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18848786?
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BC3cXisFOgsLo%3D net monthly?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Estramustine%20plus%20docetaxel%20as%20second-line%20therapy%20in%20patients%20with%20hormone-refractory%20prostate%20cancer%20resistant%20to%20docetaxel%20alone&journal=Urol%20Oncol&doi=10.1016%2Fj.urolonc.2008.07.033&volume=28&pages=152-156&publication_year=2010&author=Caffo%2CO&author=Sava%2CT&author=Comploj%2CE&author=Giampaolo%2CMA&author=Segati%2CR&author=Valduga%2CF?
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18276061?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Combination%20of%20bevacizumab%20and%20docetaxel%20in%20docetaxel-pretreated%20hormone-refractory%20prostate%20cancer%3A%20a%20phase%202%20study&journal=Eur%20Urol&doi=10.1016%2Fj.eururo.2008.01.082&volume=54&issue=5&pages=1089-1094&publication_year=2008&author=Lorenzo%2CG&author=Figg%2CWD&author=Fossa%2CSD&author=Mirone%2CV&author=Autorino%2CR&author=Longo%2CN?
• What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17535276 each month?
• What are the earnings of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2sXht1SmtLbJ?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Weekly%20high-dose%20calcitriol%20and%20docetaxel%20in%20patients%20with%20metastatic%20hormone-refractory%20prostate%20cancer%20previously%20exposed%20to%20docetaxel&journal=BJU%20Int&doi=10.1111%2Fj.1464-410X.2007.07019.x&volume=100&issue=4&pages=775-779&publication_year=2007&author=Petrioli%2CR&author=Pascucci%2CA&author=Francini%2CE&author=Marsili%2CS&author=Sciandivasci%2CA&author=Rubertis%2CG
• Revenue of http://scholar.google.com/scholar_lookup?&title=Preliminary%20report%20of%20an%20open-label%2C%20multicenter%2C%20phase%20I%2FII%20study%20of%20AT-101%20in%20combination%20with%20docetaxel%20and%20prednisone%20in%20men%20with%20docetaxel%20refractory%20prostate%20cancer&journal=J%20Clin%20Oncol&volume=27&issue=15S&publication_year=2009&author=Poiesz%2CB&author=Reeves%2CJ&author=McNulty%2CW&author=Maleski%2CJ&author=Holmlund%2CJ&author=Leopold%2CL
• Revenue of http://scholar.google.com/scholar_lookup?&title=Cetuximab%20in%20combination%20with%20docetaxel%20in%20patients%20with%20metastatic%20castration-resistant%20and%20docetaxel-refractory%20prostate%20cancer%3A%20a%20multicenter%20phase%20II%20trial%20%28SAKK%2008%2F07%29&journal=J%20Clin%20Oncol&volume=28&issue=15S&publication_year=2010&author=Cathomas%2CR&author=Rothermundt%2CC&author=Moos%2CR&author=Betticher%2CDC&author=Winterhalder%2CRC&author=Droege%2CC
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19420966 making per month?
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD1MXmtFCis7g%3D generate monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Paclitaxel%2C%20estramustine%20and%20carboplatin%20combination%20chemotherapy%20after%20initial%20docetaxel-based%20chemotherapy%20in%20castration-resistant%20prostate%20cancer&journal=Oncology&doi=10.1159%2F000217264&volume=76&issue=6&pages=442-446&publication_year=2009&author=Sella%2CA&author=Yarom%2CN&author=Zismas%2CA&author=Kovel%2CS rake in every month?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20016365 income
• How much revenue does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BC3cXivV2rsLo%3D generate?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=A%20phase%20II%20study%20of%20paclitaxel%20poliglumex%20in%20combination%20with%20transdermal%20estradiol%20for%20the%20treatment%20of%20metastatic%20castration-resistant%20prostate%20cancer%20after%20docetaxel%20chemotherapy&journal=Anticancer%20Drugs&doi=10.1097%2FCAD.0b013e3283355211&volume=21&issue=4&pages=433-438&publication_year=2010&author=Beer%2CTM&author=Ryan%2CC&author=Alumkal%2CJ&author=Ryan%2CCW&author=Sun%2CJ&author=Eilers%2CKM
• http://scholar.google.com/scholar_lookup?&title=E3803%3A%20updated%20results%20on%20phase%20II%20study%20of%20a%20weekly%20schedule%20of%20BMS-247550%20for%20patients%20with%20castrate%20refractory%20prostate%20cancer%20%28CRPC%29&journal=J%20Clin%20Oncol&volume=26&issue=15S&publication_year=2008&author=Wilding%2CG&author=Chen%2CY&author=DiPaola%2CRP&author=Carducci%2CMA&author=Liu%2CG's revenue stream
• How much money does http://scholar.google.com/scholar_lookup?&title=A%20phase%20II%20study%20of%20patupilone%20in%20patients%20with%20metastatic%20castration-resistant%20prostate%20cancer%20%28CRPC%29%20who%20have%20progressed%20after%20docetaxel&journal=J%20Clin%20Oncol&volume=27&issue=15S&publication_year=2009&author=Beardsley%2CEK&author=Saad%2CF&author=Eigl%2CB&author=Venner%2CP&author=Hotte%2CS&author=Winquist%2CE&author=Ko%2CYJ make?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19087985
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:STN:280:DC%2BD1M7mvVamtg%3D%3D earn?
• How much does http://scholar.google.com/scholar_lookup?&title=Phase%20II%20trial%20of%20weekly%20patupilone%20in%20patients%20with%20castration-resistant%20prostate%20cancer&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdn665&volume=20&pages=492-497&publication_year=2009&author=Hussain%2CA&author=DiPaola%2CRS&author=Baron%2CAD&author=Higano%2CCS&author=Tchekmedyian%2CNS&author=Johri%2CAR rake in every month?
• http://scholar.google.com/scholar_lookup?&title=ECOG%205805%3A%20a%20phase%20II%20study%20of%20eribulin%20mesilate%20%28E7389%29%20in%20patients%20with%20metastatic%20castration-resistant%20prostate%20cancer&journal=J%20Clin%20Oncol&volume=28&issue=15S&publication_year=2010&author=Stein%2CMN&author=Chen%2CY&author=Hudes%2CGR&author=Carducci%2CMA&author=Tan%2CW&author=DiPaola%2CRS's revenue stream
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17476141
• What are the total earnings of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2sXmtVGru7k%3D?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Response%20to%20vinorelbine%20with%20or%20without%20estramustine%20as%20second-line%20chemotherapy%20in%20patients%20with%20hormone-refractory%20prostate%20cancer&journal=Cancer%20J&doi=10.1097%2FPPO.0b013e3180465940&volume=13&issue=2&pages=125-129&publication_year=2007&author=Nakabayashi%2CM&author=Ling%2CJ&author=Xie%2CW&author=Regan%2CMM&author=Oh%2CWK
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16765185 generate?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Response%20to%20second-line%20chemotherapy%20in%20patients%20with%20hormone%20refractory%20prostate%20cancer%20receiving%20two%20sequences%20of%20mitoxantrone%20and%20taxanes&journal=Urology&doi=10.1016%2Fj.urology.2006.01.006&volume=67&pages=1235-1240&publication_year=2006&author=Oh%2CWK&author=Manola%2CJ&author=Babcic%2CV&author=Harnam%2CN&author=Kantoff%2CPW
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=on%20behalf%20of%20the%20TAX%20327%20investigators.%20Survival%20and%20PSA%20response%20of%20patients%20in%20the%20TAX%20327%20study%20who%20crossed%20over%20to%20receive%20docetaxel%20after%20mitoxantrone%20or%20vice%20versa&journal=Ann%20Oncol&volume=19&pages=1749-1753&publication_year=2008&author=Berthold%2CDR&author=Pond%2CGR&author=Wit%2CR&author=Eisenberger%2CM&author=Tannock%2CIF?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16456811?
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD28Xis1agtrY%3D bring in each month?
• What's the income of http://scholar.google.com/scholar_lookup?&title=First-%20and%20second-line%20chemotherapy%20with%20docetaxel%20or%20mitoxantrone%20in%20patients%20with%20hormone-refractory%20prostate%20cancer%3A%20does%20sequence%20matter%3F&journal=Cancer&doi=10.1002%2Fcncr.21695&volume=106&issue=5&pages=1041-1046&publication_year=2006&author=Michels%2CJ&author=Montemurro%2CT&author=Murray%2CN&author=Kollmannsberger%2CC&author=Chi%2CNK?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Ixabepilone%2C%20mitoxantrone%2C%20and%20prednisone%20in%20patients%20with%20metastatic%20castration-resistant%20prostate%20cancer%20refractory%20to%20docetaxel-based%20therapy%3A%20a%20phase%20II%20study%20of%20the%20DOD%20Prostate%20Cancer%20Clinical%20Trials%20Consortium&journal=J%20Clin%20Oncol&volume=27&issue=15S&publication_year=2009&author=Small%2CE&author=Harzstark%2CA&author=Weinberg%2CVK&author=Smith%2CDC&author=Mathew%2CP&author=Beer%2CT making per month?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18400264's revenue stream
• Revenue of http://scholar.google.com/scholar_lookup?&title=Biweekly%20doxorubicin%2Fketoconazole%20as%20second-line%20treatment%20in%20docetaxel-resistant%2C%20hormone-refractory%20prostate%20cancer&journal=Urology&doi=10.1016%2Fj.urology.2008.02.048&volume=71&pages=1181-1185&publication_year=2008&author=Lainakis%2CG&author=Nikos%2CA&author=Gerassimos%2CA&author=Michael%2CC&author=Iraklis%2CM&author=Konstantinos%2CL
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Phase%20II%20trial%20of%20nonpegylated%20liposomal%20doxorubicin%20and%20low-dose%20prednisone%20in%20second-line%20chemotherapy%20for%20hormone-refractory%20prostate%20cancer%3A%20a%20translational%20study&journal=J%20Clin%20Oncol&volume=28&issue=15S&publication_year=2010&author=Montanari%2CM&author=Fabbri%2CF&author=Frassineti%2CL&author=Rondini%2CE&author=Mattioli%2CR&author=Luzi%20Fedeli%2CS?
• What's the monthly income of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD2cXptlSksro%3D?
• How much income is http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20oral%20bis%20%28aceto%29%20ammine%20dichloro%20%28cycloexamine%29%20platinum%20%28IV%29%20%28JM-216%2C%20BMS-182751%29%20given%20daily%20x%205%20in%20hormone%20refractory%20prostate%20cancer%20%28HRPC%29&journal=Investig%20New%20Drugs&doi=10.1023%2FB%3ADRUG.0000047109.76766.84&volume=23&pages=79-84&publication_year=2005&author=Latif%2CT&author=Wood%2CL&author=Connell%2CC&author=Smith%2CDC&author=Vaughn%2CD&author=Lebwohl%2CD earning monthly?
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19179557
• What's the monthly money flow for https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:STN:280:DC%2BD1M3jt1CksQ%3D%3D?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Combining%20carboplatin%20and%20etoposide%20in%20docetaxel-pretreated%20patients%20with%20castration-resistant%20prostate%20cancer%3A%20a%20prospective%20study%20evaluating%20also%20neuroendocrine%20features&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdn694&volume=20&pages=703-708&publication_year=2009&author=Loriot%2CY&author=Massard%2CC&author=Gross-Goupil%2CM&author=Palma%2CM&author=Escudier%2CB&author=Bossi%2CA?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Interim%20results%20of%20a%20phase%20II%20trial%20of%20pemetrexed%2C%20oxaliplatin%20as%202nd%2F3rd%20line%20therapy%20in%20hormone%20refractory%20prostate%20cancer&journal=J%20Clin%20Oncol&volume=26&publication_year=2008&author=Dorff%2CTB&author=Groshen%2CSG&author=Wei%2CD&author=Korn%2CC&author=Goldkorn%2CA&author=Quinn%2CDI?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21036758?
• What is the earnings of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BC3MXktF2n?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Metronomic%20oral%20cyclophosphamide-prednisone%20chemotherapy%20is%20an%20effective%20treatment%20for%20metastatic%20hormone-refractory%20prostate%20cancer%20after%20docetaxel%20failure&journal=Anticancer%20Res&volume=30&issue=10&pages=4317-4323&publication_year=2010&author=Ladoire%2CS&author=Eymard%2CJC&author=Zanetta%2CS&author=Mignot%2CG&author=Martin%2CE&author=Kermarrec%2CI
• What are the earnings of https://link.springer.com/doi/10.1007/s12032-009-9218-8?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19365737
• What's the profit of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BC3cXlsVSqtro%3D?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Clinical%20outcome%20of%20patients%20with%20docetaxel-resistant%20hormone-refractory%20prostate%20cancer%20treated%20with%20second-line%20cyclophosphamide-based%20metronomic%20chemotherapy&journal=Med%20Oncol&doi=10.1007%2Fs12032-009-9218-8&volume=27&issue=2&pages=363-367&publication_year=2010&author=Nelius%2CT&author=Klatte%2CT&author=Riese%2CW&author=Haynes%2CA&author=Filleur%2CS
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19622584
• How much revenue does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD1MXptl2gtr8%3D generate?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Clinical%20and%20pharmacodynamic%20evaluation%20of%20metronomic%20cyclophosphamide%2C%20celecoxib%2C%20and%20dexamethasone%20in%20advanced%20hormone-refractory%20prostate%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-08-3317&volume=15&issue=15&pages=4954-4962&publication_year=2009&author=Fontana%2CA&author=Galli%2CL&author=Fioravanti%2CA&author=Orlandi%2CP&author=Galli%2CC&author=Landi%2CL
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19605506 rake in every month?
• What's the monthly income of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:STN:280:DC%2BD1MjntFOquw%3D%3D?
• How much does http://scholar.google.com/scholar_lookup?&title=A%20phase%20II%20study%20of%20pemetrexed%20as%20second-line%20chemotherapy%20for%20the%20treatment%20of%20metastatic%20castrate-resistant%20prostate%20cancer%20%28CRPC%29%3B%20Hoosier%20Oncology%20Group%20GUO3-67&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdp244&volume=20&pages=1971-1976&publication_year=2009&author=Hahn%2CNM&author=Zon%2CRT&author=Yu%2CM&author=Ademuyiwa%2CFO&author=Jones%2CT&author=Dugan%2CW pull in?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17320676 income
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Phase%20II%20trial%20of%20gemcitabine%2C%20prednisone%2C%20and%20zoledronic%20acid%20in%20pretreated%20patients%20with%20hormone%20refractory%20prostate%20cancer&journal=Urology&doi=10.1016%2Fj.urology.2006.10.007&volume=69&pages=347-351&publication_year=2007&author=Lorenzo%2CG&author=Autorino%2CR&author=Giuliano%2CM&author=Morelli%2CE&author=Giordano%2CA&author=Napodano%2CA?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20483588 pull in?
• https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BC3cXntlajtb8%3D's total income per month
• How much does http://scholar.google.com/scholar_lookup?&title=The%20interval%20from%20the%20last%20cycle%20of%20docetaxel-based%20chemotherapy%20to%20progression%20is%20associated%20with%20the%20efficacy%20of%20subsequent%20docetaxel%20in%20patients%20with%20prostate%20cancer&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2010.04.010&volume=46&pages=1770-1772&publication_year=2010&author=Loriot%2CY&author=Massard%2CC&author=Gross-Goupil%2CM&author=Palma%2CM&author=Escudier%2CB&author=Bossi%2CA gross monthly?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20230389 make?
• Financial intake of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BC3cXhsVSksrfE
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Docetaxel%20reintroduction%20in%20patients%20with%20metastatic%20castration-resistant%20docetaxel-sensitive%20prostate%20cancer%3A%20a%20retrospective%20multicentre%20study&journal=BJU%20Int&doi=10.1111%2Fj.1464-410X.2010.09296.x&volume=106&issue=7&pages=974-978&publication_year=2010&author=Eymard%2CJC&author=Oudard%2CS&author=Gravis%2CG&author=Ferrero%2CJM&author=Theodore%2CC&author=Joly%2CF?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12966410
• Learn how profitable https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD3sXntVKnsr4%3D is on a monthly basis
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Intermittent%20chemotherapy%20in%20metastatic%20androgen-independent%20prostate%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6601232&volume=89&pages=968-970&publication_year=2003&author=Beer%2CTM&author=Garzotto%2CM&author=Henner%2CWD&author=Eilers%2CKM&author=Wersinger%2CEM each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Intermittent%20chemotherapy%20in%20patients%20with%20metastatic%20androgen-independent%20prostate%20cancer%3A%20results%20from%20ASCENT%2C%20a%20double-blinded%20randomized%20comparison%20of%20high-dose%20calcitriol%20plus%20docetaxel%20with%20placebo%20plus%20docetaxel&journal=Cancer&volume=112&issue=1&pages=326-330&publication_year=2008&author=Beer%2CTM&author=Ryan%2CCW&author=Venner%2CPM&author=Petrylak%2CDP&author=Chatta%2CGS&author=Ruether%2CJD&author=Investigators%2CASCENT make?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16442593?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Randomized%20phase%20II%20study%20comparing%20paclitaxel%20and%20carboplatin%20versus%20mitoxantrone%20in%20patients%20with%20hormone-refractory%20prostate%20cancer&journal=Urology&doi=10.1016%2Fj.urology.2005.08.046&volume=67&issue=2&pages=354-359&publication_year=2006&author=Cabrespine%2CA&author=Guy%2CL&author=Khenifar%2CE&author=Cur%C3%A8%2CH&author=Fleury%2CJ&author=Penault-Llorca%2CF?
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20722827 have?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Metronomic%20cyclophosphamide%20in%20elderly%20patients%20with%20advanced%2C%20castration-resistant%20prostate%20cancer&journal=J%20Am%20Geriatr%20Soc&doi=10.1111%2Fj.1532-5415.2010.02833.x&volume=58&pages=986-988&publication_year=2010&author=Fontana%2CA&author=Bocci%2CG&author=Galli%2CL&author=D%E2%80%99Arcangelo%2CM&author=Derosa%2CL&author=Fioravanti%2CA
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20066005 is on a monthly basis
• What's https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BC3cXlvFOjtrk%3D's gross income?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Optimizing%20the%20use%20of%20docetaxel%20in%20men%20with%20castration-resistant%20metastatic%20prostate%20cancer&journal=Prostate%20Cancer%20Prostatic%20Dis&doi=10.1038%2Fpcan.2009.62&volume=13&pages=108-116&publication_year=2010&author=Armstrong%2CAJ&author=George%2CDJ
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20008841?
• https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BC3cXotF2g's total income per month
• Find out how much http://scholar.google.com/scholar_lookup?&title=Prediction%20of%20survival%20following%20first-line%20chemotherapy%20in%20men%20with%20castration-resistant%20metastatic%20prostate%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-09-2514&volume=16&issue=1&pages=203-211&publication_year=2010&author=Armstrong%2CAJ&author=Garrett-Mayer%2CE&author=Wit%2CR&author=Tannock%2CI&author=Eisenberger%2CM earns monthly
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20159814
• How much profit does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BC3cXltFGhsbw%3D make?
• How much income is http://scholar.google.com/scholar_lookup?&title=Phase%20II%20multicenter%20study%20of%20abiraterone%20acetate%20plus%20prednisone%20therapy%20in%20patients%20with%20docetaxel-treated%20castration-resistant%20prostate%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.25.9259&volume=28&pages=1496-1501&publication_year=2010&author=Danila%2CDC&author=Morris%2CMJ&author=Bono%2CJS&author=Ryan%2CCJ&author=Denmeade%2CSR&author=Smith%2CMR earning monthly?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Activity%20of%20ketoconazole%20after%20taxane-based%20chemotherapy%20in%20castration-resistant%20prostate%20cancer&journal=BJU%20Int&volume=105&issue=10&pages=132-139&publication_year=2010&author=Nakabayashi%2CM&author=Oh%2CWK&author=Jacobus%2CS&author=Regan%2CMM&author=Taplin%2CME&author=Kantoff%2CPW?
• See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18182976 makes per month
• What's the income of https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD1cXisF2quw%3D%3D?
• How profitable is http://scholar.google.com/scholar_lookup?&title=A%20phase%20II%20study%20investigating%20the%20re-induction%20of%20endocrine%20sensitivity%20following%20chemotherapy%20in%20androgen-independent%20prostate%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6604051&volume=98&pages=22-24&publication_year=2008&author=Shamash%2CJ&author=Davies%2CA&author=Ansell%2CW&author=Mcfaul%2CS&author=Wilson%2CP&author=Oliver%2CT?
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19342958?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Novel%20secondary%20hormonal%20therapy%20in%20advanced%20prostate%20cancer%3A%20an%20update&journal=Curr%20Opin%20Urol&doi=10.1097%2FMOU.0b013e328329b73a&volume=19&issue=3&pages=315-321&publication_year=2009&author=Allen%2CEM&author=Ryan%2CCJ?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19013008's gross income?
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD1MXns1Clu7k%3D make?
• How much does http://scholar.google.com/scholar_lookup?&title=The%20evolving%20role%20of%20oestrogens%20and%20their%20receptors%20in%20the%20development%20and%20progression%20of%20prostate%20cancer&journal=Eur%20Urol&doi=10.1016%2Fj.eururo.2008.10.035&volume=55&pages=533-542&publication_year=2009&author=Bonkhoff%2CH&author=Berges%2CR make?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17062688 generate?
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/articles/cas-redirect/1:CAS:528:DC%2BD28XhtFWhsbnE make?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Bcl-2%20expression%20as%20a%20predictive%20marker%20of%20hormone-refractory%20prostate%20cancer%20treated%20with%20taxane-based%20chemotherapy&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-0147&volume=12&issue=20&pages=6116-6124&publication_year=2006&author=Yoshino%2CT&author=Shiina%2CH&author=Urakami%2CS&author=Kikuno%2CN&author=Yoneda%2CT&author=Shigeno%2CK
• How much does http://scholar.google.com/scholar_lookup?&title=Cancer%20and%20Leukemia%20Group%20B%209480.%20Prognostic%20significance%20of%20plasma%20vascular%20endothelial%20growth%20factor%20levels%20in%20patients%20with%20hormone-refractory%20prostate%20cancer%20treated%20on%20Cancer%20and%20Leukemia%20Group%20B%209480&journal=Clin%20Cancer%20Res&volume=7&issue=7&pages=1932-1936&publication_year=2001&author=George%2CDJ&author=Halabi%2CS&author=Shepard%2CTF&author=Vogelzang%2CNJ&author=Hayes%2CDF&author=Small%2CEJ generate monthly?
• How much income is http://scholar.google.com/scholar_lookup?&title=Dasatinib%20and%20docetaxel%20combination%20treatment%20for%20patients%20with%20castration-resistant%20progressive%20prostate%20cancer%3A%20a%20phase%20I%2FII%20study&journal=J%20Clin%20Oncol&volume=27&issue=15S&publication_year=2009&author=Araujo%2CJ&author=Armstrong%2CAJ&author=Braud%2CEL&author=Posadas%2CE&author=Lonberg%2CM&author=Gallick%2CGE earning monthly?
• Income figures for https://citation-needed.springer.com/v2/references/10.1007/s12032-011-9855-6?format=refman&flavour=references
• What's the monthly income of https://link.springer.com/article/10.1007/s12032-011-9855-6/search?sortBy=newestFirst&dc.creator=Giuseppe%20Colloca?
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Giuseppe%20Colloca?
• What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Giuseppe%20Colloca%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much income is https://link.springer.com/article/10.1007/s12032-011-9855-6/search?sortBy=newestFirst&dc.creator=Antonella%20Venturino earning monthly?
• Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Antonella%20Venturino
• Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Antonella%20Venturino%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What is the earnings of https://link.springer.com/article/10.1007/s12032-011-9855-6/search?sortBy=newestFirst&dc.creator=Franco%20Checcaglini?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Franco%20Checcaglini's financial summary
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Franco%20Checcaglini%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's https://link.springer.com/article/10.1007/s12032-011-9855-6/mailto:[email protected]'s gross income?
• How much does https://s100.copyright.com/AppDispatchServlet?title=Second-line%20chemotherapy%20in%20metastatic%20docetaxel-resistant%20prostate%20cancer%3A%20a%20review&author=Giuseppe%20Colloca%20et%20al&contentID=10.1007%2Fs12032-011-9855-6©right=Springer%20Science%2BBusiness%20Media%2C%20LLC&publication=1357-0560&publicationDate=2011-02-20&publisherName=SpringerNature&orderBeanReset=true generate monthly?
• Earnings of https://citation-needed.springer.com/v2/references/10.1007/s12032-011-9855-6?format=refman&flavour=citation
• How much does https://link.springer.com/article/10.1007/s12032-011-9855-6/search?query=Castration-resistance&facet-discipline="Medicine%20%26%20Public%20Health" gross monthly?
• What are the earnings of https://link.springer.com/article/10.1007/s12032-011-9855-6/search?query=Chemotherapy&facet-discipline="Medicine%20%26%20Public%20Health"?
• See how much https://link.springer.com/article/10.1007/s12032-011-9855-6/search?query=Docetaxel&facet-discipline="Medicine%20%26%20Public%20Health" makes per month
• How much profit does https://link.springer.com/article/10.1007/s12032-011-9855-6/search?query=Prostate%20cancer&facet-discipline="Medicine%20%26%20Public%20Health" generate?
• How much profit is https://link.springer.com/article/10.1007/s12032-011-9855-6/researchers/75021791SN making per month?
• See how much https://link.springer.com/journals/a/1 makes per month
• What's the monthly money flow for https://link.springer.com/books/a/1?
• What's https://link.springer.com/journals's gross income?
• What is the monthly revenue of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
• How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research pull in monthly?
• How much does https://www.springernature.com/gp/products gross monthly?
• Learn about the earnings of https://www.springernature.com/gp/librarians
• How much does https://www.springernature.com/gp/societies net monthly?
• Find out how much https://www.springernature.com/gp/partners earns monthly
• What's the financial intake of https://www.springer.com/?
• https://www.nature.com/'s total income per month
• Explore the financials of https://www.biomedcentral.com/
• Get to know https://www.palgrave.com/'s earnings
• What's the total monthly financial gain of https://www.apress.com/?
• How much profit is https://link.springer.com/brands/discover making per month?
• https://www.springernature.com/gp/legal/ccpa's financial summary
• How much does https://www.springernature.com/gp/info/accessibility pull in monthly?
• How much revenue does https://link.springer.com/termsandconditions generate?
• How much income does https://support.springernature.com/en/support/home have?
• What is the earnings of https://link.springer.com/legal-notice?
• How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations rake in every month?
• What's the monthly income of https://www.springernature.com/?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

Emails and Hosting {✉️}

Mail Servers:

• mx.zoho.eu
• mx2.zoho.eu
• mx3.zoho.eu

Name Servers:

• josh.ns.cloudflare.com
• zita.ns.cloudflare.com

CDN Services {📦}

• Crossref